If you are a medical practitioner (GP) seeking information about supporting a transgender or gender diverse patient this document may assist you.
All practitioners should carefully explore the risks and expectations of Hormone Replacement Therapy with a patient/client. Consider these extracts from the WPATH Standards of Care as a starting point for discussion:
Feminising Hormones Risks and Timelines WPATH
Masculinising Hormones Risks and Timelines WPATH
THSA reminds that these are tools for medical practitioners to provide patient informed care with the support of the practitioner. THSA does not endorse nor promote, in any way, self medication.
Note – Primoteston injectable is no longer on PBS and can only be written on Private Prescription as on February 1st, 2018.
For trans masculine folk wishing to access hormone therapy, it can be a bit muggy knowing how to access anything but hopefully this clears it up. This is taken directly from, and also hyperlinked to, the PBS federal guidelines under Medicare:
Prescription guidelines under PBS
Of importance are the guidelines which are applicable for most (not all) trans masc:
- Androgen deficiency (THSA note – this is the most applicable to trans masc folk)
- Patient must have an established pituitary or testicular disorder.
- Must be treated by a specialist paediatric endocrinologist, specialist urologist, specialist endocrinologist or a Fellow of the Australasian Chapter of Sexual Health Medicine; or in consultation with one of these specialists; OR have an appointment to be assessed by one of these specialists.
The name of the specialist must be included in the authority application.”
This means a General Practitioner can prescribe once a referral has been written and an appointment made to a specialist as noted above.
THSA notes that in no way is this an endorsement not to access some health professionals and specialists. THSA values the work of practitioner specialists such as Endocrinologists and Sexual Health Physicians and encourages folk’ access the services they need in collaboration with their General Practitioner. This does however, empower GPs who feel capable and competent to be able to provide a service, to know they are able to do so without the need of a psychologist or psychiatrist if not deemed required for the indivudal.
Medication Prescribing for Transgender Women / Trans-Feminine Persons
Medications prescribed to those assigned male at birth (AFAB) do not have the same PBS and Medicare restrictions as testosterone. For example, androgen blockers such as Spironolactone or Cyproterone are considered “General Schedule ” and do not have any “Authority” requirement as are medications containing estrogen/oestrodiol.
Trans Health SA acknowledges this means a suitably educated medical practitioner (GP) can prescribe these medications however it is highly encouraged to do so via a trained and experienced provider in trans and gender diverse health.